Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization.
The association between peripheral vascular disease and outcomes after percutaneous coronary intervention was examined in the Do Tirofiban and Reopro Give Similar Efficacy Outcome Trial (TARGET). After adjustments in a multivariate model, a history of peripheral vascular disease was found to be associated with a two- to threefold increase in mortality at 1 year after coronary stent placement.
Chiu
John H
JH
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Topol
Eric J
EJ
Whitlow
Patrick L
PL
Hsu
Amy P
AP
Tuzcu
E Murat
EM
Franco
Irving
I
Moliterno
David J
DJ
D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D015897:Comorbidity; D003327:Coronary Disease / Q000150:complications / Q000401:mortality* / Q000628:therapy*; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000209:etiology; D016491:Peripheral Vascular Diseases / Q000150:complications*; D011237:Predictive Value of Tests; D015995:Prevalence; D011379:Prognosis; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D015607:Stents; D016019:Survival Analysis; D016896:Treatment Outcome